Bone Marrow Transplantation - Table of Contents alert Volume 47 Issue 4

TABLE OF CONTENTS Volume 47, Issue 4 (April 2012) In this issue Editorial Review Original Articles Letters to the Editor Corrigendum Also new AOP Advertisement BD Reagents for Blood Cell Disorders Part of the building blocks to support patient care for blood cell disorders, BD Biosciences reagents provide a full spectrum of color choices, allowing you to analyze multiple parameters simultaneously and access a whole new world of information and insight. Welcome to a more colorful worldSM. bdbiosciences.com/go/color Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement IBMS BoneKEy Webinars Sign up now for the next webinar LIVE expert led presentations on hot topics in the bone field presented as a PowerPoint lecture, followed by a discussion panel with world-renowned bone scientists and clinicians. Sign up for the next webinar and visit video presentations and summaries of previous webinars.   Editorial Top Non-invasive mechanical ventilation in hematology patients with hypoxemic acute respiratory failure: a false belief? E Azoulay and V Lemiale Bone Marrow Transplant 2012 47: 469-472; 10.1038/bmt.2011.232 Full Text Review Top Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30 N Grulke, C Albani and H Bailer Bone Marrow Transplant 2012 47: 473-482; advance online publication, May 23, 2011; 10.1038/bmt.2011.107 Abstract | Full Text Original Articles Top STEM CELL PROCUREMENT A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor S Abhyankar, S DeJarnette, O Aljitawi, S Ganguly, D Merkel and J McGuirk Bone Marrow Transplant 2012 47: 483-487; advance online publication, July 4, 2011; 10.1038/bmt.2011.133 Abstract | Full Text Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation J Waterman, L Rybicki, B Bolwell, E Copelan, B Pohlman, J Sweetenham, R Dean, R Sobecks, S Andresen and M Kalaycio Bone Marrow Transplant 2012 47: 488-493; advance online publication, May 16, 2011; 10.1038/bmt.2011.109 Abstract | Full Text CORD BLOOD STEM CELLS Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors N S Majhail, C G Brunstein, R Shanley, K Sandhu, B McClune, B Oran, E D Warlick, J E Wagner and D J Weisdorf Bone Marrow Transplant 2012 47: 494-498; advance online publication, May 23, 2011; 10.1038/bmt.2011.114 Abstract | Full Text ALLOGRAFTING Wilms’ tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT X-S Zhao, S Jin, H-H Zhu, L-P Xu, D-H Liu, H Chen, K-Y Liu and X-J Huang Bone Marrow Transplant 2012 47: 499-507; advance online publication, June 6, 2011; 10.1038/bmt.2011.121 Abstract | Full Text Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT S Yoshihara, E Maruya, K Taniguchi, K Kaida, R Kato, T Inoue, T Fujioka, H Tamaki, K Ikegame, M Okada, T Soma, K Hayashi, N Fujii, T Onuma, Y Kusunoki, H Saji and H Ogawa Bone Marrow Transplant 2012 47: 508-515; advance online publication, June 20, 2011; 10.1038/bmt.2011.131 Abstract | Full Text AUTOGRAFTING Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma A I Chen, R S Negrin, A McMillan, J A Shizuru, L J Johnston, R Lowsky, D B Miklos, S Arai, W-K Weng, G G Laport and K Stockerl-Goldstein Bone Marrow Transplant 2012 47: 516-521; advance online publication, May 23, 2011; 10.1038/bmt.2011.106 Abstract | Full Text Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America J Palma, D F Sasso, G Dufort, K Koop, C Sampor, B Diez, L Richard, L Castillo and G L Chantada Bone Marrow Transplant 2012 47: 522-527; advance online publication, May 23, 2011; 10.1038/bmt.2011.108 Abstract | Full Text Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation S W Bokhari, L Watson, S Nagra, M Cook, J L Byrne, C Craddock and N H Russell Bone Marrow Transplant 2012 47: 528-534; advance online publication, July 11, 2011; 10.1038/bmt.2011.138 Abstract | Full Text Current status of allogeneic HST for chronic myelomonocytic leukemia H Cheng, V G Kirtani and U Gergis Bone Marrow Transplant 2012 47: 535-541; advance online publication, July 11, 2011; 10.1038/bmt.2011.141 Abstract | Full Text Autologous transplantation in CLL patients with B and C Binet stages: final results of the prospective randomized GOELAMS LLC 98 trial A Brion, B Mahé, B Kolb, B Audhuy, P Colombat, H Maisonneuve, C Foussard, A Bureau, C Ferrand, J F Lesesve, M C Béné, P Feugier and for the Groupe Ouest Est d’Etude des Leucémies et autres Maladies du Sang Bone Marrow Transplant 2012 47: 542-548; advance online publication, July 4, 2011; 10.1038/bmt.2011.117 Abstract | Full Text Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs C Faucher, A G Le Corroller Soriano, B Esterni, N Vey, A M Stoppa, C Chabannon, M Mohty, M Michallet, J O Bay, D Genre, D Maraninchi, P Viens, J P Moatti and D Blaise Bone Marrow Transplant 2012 47: 549-555; advance online publication, July 4, 2011; 10.1038/bmt.2011.126 Abstract | Full Text Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants P B Mumby, C Hurley, M Samsi, S Thilges, M Parthasarathy and P J Stiff Bone Marrow Transplant 2012 47: 556-561; advance online publication, June 20, 2011; 10.1038/bmt.2011.129 Abstract | Full Text MICROBIAL ISSUES Voriconazole as primary antifungal prophylaxis in children undergoing allo-SCT J R Molina, J Serrano, J Sánchez-García, A Rodríguez-Villa, P Gómez, D Tallón, V Martín, G Rodríguez, R Rojas, C Martín, F Martínez, M A Álvarez and A Torres Bone Marrow Transplant 2012 47: 562-567; advance online publication, May 16, 2011; 10.1038/bmt.2011.111 Abstract | Full Text POST-TRANSPLANT EVENTS Uptake and outcome of assisted reproductive techniques in long-term survivors of SCT A Babb, N Farah, C Lyons, K Lindsay, N Reddy, J Goldman, J F Apperley and N Salooja Bone Marrow Transplant 2012 47: 568-573; advance online publication, July 11, 2011; 10.1038/bmt.2011.134 Abstract | Full Text Respiratory failure in patients undergoing allogeneic hematopoietic SCT—a randomized trial on early non-invasive ventilation based on standard care hematology wards M Wermke, S Schiemanck, G Höffken, G Ehninger, M Bornhäuser and T Illmer Bone Marrow Transplant 2012 47: 574-580; advance online publication, September 19, 2011; 10.1038/bmt.2011.160 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation L Johnston, M Florek, R Armstrong, J S McCune, S Arai, J Brown, G Laport, R Lowsky, D Miklos, J Shizuru, K Sheehan, P Lavori and R Negrin Bone Marrow Transplant 2012 47: 581-588; advance online publication, May 9, 2011; 10.1038/bmt.2011.104 Abstract | Full Text Letters to the Editor Top A double cure: Omenn syndrome and β thalassaemia successfully treated with mismatched unrelated donor transplantation V Wootten, N Goulden, P Veys and W Qasim Bone Marrow Transplant 2012 47: 589-590; advance online publication, May 23, 2011; 10.1038/bmt.2011.115 Full Text Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection G Grigoriadis, C C Chang, P Walker, S Patil, S Avery, O Morrissey and A Spencer Bone Marrow Transplant 2012 47: 591-592; advance online publication, June 13, 2011; 10.1038/bmt.2011.116 Full Text Clinical features of calcineurin inhibitor-induced pain syndrome after allo-SCT K Kakihana, K Ohashi, Y Murata, M Tsubokura, T Kobayashi, T Yamashita, H Sakamaki and H Akiyama Bone Marrow Transplant 2012 47: 593-595; advance online publication, May 30, 2011; 10.1038/bmt.2011.120 Full Text A prognostic score with pretransplant serum ferritin and disease status predicts outcome following reduced-intensity SCT M Tanaka, T Tachibana, A Numata, H Takasaki, K Matsumoto, A Maruta, Y Ishigatsubo and H Kanamori Bone Marrow Transplant 2012 47: 596-597; advance online publication, June 6, 2011; 10.1038/bmt.2011.122 Full Text Extramedullary relapse following allogeneic BMT in a postpartum female patient with acute lymphoblastic leukemia X He, D Wu and A Sun Bone Marrow Transplant 2012 47: 598-599; advance online publication, July 4, 2011; 10.1038/bmt.2011.123 Full Text Autoimmune-like hepatitis following unrelated BMT successfully treated with rituximab A Narita, H Muramatsu, Y Takahashi, H Sakaguchi, S Doisaki, N Nishio, A Hama, A Shimada, M Ito and S Kojima Bone Marrow Transplant 2012 47: 600-602; advance online publication, June 13, 2011; 10.1038/bmt.2011.124 Full Text Dermatomyositis developed in a recipient of allogeneic BMT; the differentiation of chronic GVHD and autoimmune disease K Sakamoto, T Imamura, F Niwa, S Komori, Y Ishihara, K Shiga, M Ito and H Hosoi Bone Marrow Transplant 2012 47: 603-604; advance online publication, June 13, 2011; 10.1038/bmt.2011.125 Full Text Donors as research subjects: a challenge R King, A H Schmidt, P Costeas and T Egeland Bone Marrow Transplant 2012 47: 605-606; advance online publication, June 13, 2011; 10.1038/bmt.2011.127 Full Text Environmental conditions are important for establishing and evaluating pre-clinical models of GVHD M E Christensen, L J Sinfield, H Cullup, N J Waterhouse, K Atkinson and A M Rice Bone Marrow Transplant 2012 47: 607-609; advance online publication, June 27, 2011; 10.1038/bmt.2011.128 Full Text Recurrence of Clostridium difficile infection after total colectomy in an allogeneic stem cell transplant patient K Chang, L M B Kreuziger, K Angell, J-A Young and C Ustun Bone Marrow Transplant 2012 47: 610-611; advance online publication, June 20, 2011; 10.1038/bmt.2011.132 Full Text Donor cell leukaemia after allogeneic haematopoietic SCT followed by prolonged thalidomide maintenance for multiple myeloma T S Y Chan, W-Y Au, K Lam, Y-F Lam, C-C So, A Y H Leung, E Tse, A K W Lie and Y-L Kwong Bone Marrow Transplant 2012 47: 612-615; advance online publication, June 27, 2011; 10.1038/bmt.2011.136 Full Text Corrigendum Top Prognostic impact of iron parameters in patients undergoing allo-SCT G N Bazuaye, A Buser, S Gerull, A Tichelli and M Stern Bone Marrow Transplant 2012 47: 616; 10.1038/bmt.2012.47 Full Text Advertisement 90 page eBook --- download now for free! Published in January 2012 Key Advances in Medicine summarizes the key clinical studies published in 2011 and highlights the trends to watch for in 2012. The perfect resource for busy medical students, physicians, and clinical researchers who want to catch up with the medical literature from 2011. Don't miss out!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.